Both arms had appropriate dose escalation to usual max dosages as once-weekly SubQ injections for 16 months resulting in an average of 20% weight loss for tirzepatide and 14% for semaglutide
That limitation is what pushed many people toward injections in the first place and what makes a properly formulated sublingual strip such a meaningful advancement
A recent study involving genetic regulation and pharmacological experiments in GLP-1R KO mice confirmed that GLP-1R signaling may be immunoregulatory, and that GLP-1R deficiency accelerates rejection reactions in a chronic heart transplant model induced by CTLA4-Ig (cytotoxic T lymphocyte-associated antigen-4) tolerance [16]
GLP-1: Slows digestion Lowers appetite Helps the body release insulin only when blood sugar is high GLP-1 medications mimic these effects
Cirrhosis and liver disorders Carnitine deficiency has been associated with cirrhosis [5]
In Part 3, we outlined reasons for optimism that the impacts of incretin-based therapies could exceed those assumed in our central scenario largely due to their emerging use in treating a broader range of diseases, and potentially even in disease prevention